Updated: May 19, 2026

Sravan Kumar Emany

ASRTAssertio Holdings, Inc.SEC CIK: 0001897662
Estimated Net Worth
$5.28 Million0.0%vs Last Year
Last Updated: May 19, 2026 11:52 PM EST

Transaction Summary

Total Transactions25
Buy-Sell Ratio0.67
Buy Transactions2
Sell Transactions3

Transaction Volume

Total Volume$108.84K
Net Volume$691.83K
Buy Volume$400.33K
Sell Volume-$291.49K

Trade Analysis

AVG Trade Size-$27.65K
Largest Trade$300.12K
Most Active MonthNov
Most Active Year2024

Trading Sentiment

OverallBullish
Recent TradeNeutral
Last 90 Days0 Trades
ConvictionNone

Net Worth & Trading Activity Over Time

Loading...

Monthly Trading Pattern

Loading...

Past Insider Trading and Trends

Sravan Kumar Emany has an estimated net worth of $5.28 Million. This is based on reported shares across multiple companies, which include IRONWOOD PHARMACEUTICALS INC, Assertio Holdings, Inc., Beam Therapeutics Inc., and Kyverna Therapeutics, Inc..



2024 was Sravan Kumar Emany's most active year for acquiring shares with 9 total transactions. Sravan Kumar Emany's most active month to acquire stocks was the month of February. 2024 was Sravan Kumar Emany's most active year for disposing of shares, totalling 4 transactions. Sravan Kumar Emany's most active month to dispose stocks was the month of October. 2023 saw Sravan Kumar Emany paying a total of $300,119.04 for 351,304 shares, this is the most they've acquired in one year. In 2024 Sravan Kumar Emany cashed out on 107,733 shares for a total of $782,110.08, their largest year based on trade value.

Holdings & Transactions

ASRTassertio holdings, inc.
Updated: May 06, 2026VIEW QUOTE
Form TypeSEC Filing
0.264.85K23.86KMay 05View
0.58134.97K366.30KMay 07View
0.76134.97K312.55KMay 23View
203.88K203.88KNov 14View
View
BEAMbeam therapeutics inc.
Chief Financial Officer
Updated: Apr 02, 2026VIEW QUOTE
Form TypeSEC Filing
0.4331.75K105.46KMar 31View
63.50K63.50KJan 31View
-0.086.29K$27.10-$170.57K73.71KDec 31View
240.00K240.00KDec 31View
View
KYTXkyverna therapeutics, inc.
Updated: Feb 26, 2026VIEW QUOTE
Form TypeSEC Filing
53.95K53.95KFeb 24View
View
IRWDironwood pharmaceuticals inc
SVP, COO and CFO
Updated: Nov 20, 2024VIEW QUOTE
Form TypeSEC Filing
-0.0311.00K$4.08-$44.88K309.57KNov 18View
-0.0518.28K$6.64-$121.38K320.57KMay 16View
338.85KMar 08View
0.0410.68K$9.38$100.22K301.73KMar 04View
0.4397.97K323.71KFeb 12View
-0.1541.33K$14.90-$615.85K225.74KFeb 08View
0.4785.00K267.07KJan 17View
-0.046.66K$9.44-$62.88K182.07KNov 16View
0.2436.07K$8.32$300.12K188.73KSep 15View
1.42111.35K189.78KMar 08View
-0.086.58K$11.56-$76.04K78.42KNov 21View
85.00K85.00KDec 06View
View